BioSpace News Archive

There has been a groundswell of interest in the application of nanotechnology for developing drug delivery systems, on account of unique properties nanoparticles have in vitro and in vivo.

The global epigenetics market is expected to grow at a fast paced CAGR in the next few years, owing to factors such as extensive use in the research of developmental and disease process, and growing importance of Life Science.

One of the leading causes of death is cardiovascular diseases followed by cancer.

Presence of a large number of small and large companies makes the global digestive enzymes market competitive in nature.

Ability to monitor remote patient on real-time basis is the key factor driving the growth of tele-intensive care unit.

SpendEdge, a leading provider of procurement market intelligence solutions, has announced the completion of their latest article on the keys to evaluate your inventory management process for biomedical devices.

Some two billion possible agents are going to be tested during the world’s largest computer-aided screening project. Austrian project partners include the biotech start-up Innophore, the University of Graz and acib, the Austrian Centre of Industrial Biotechnology.

Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced complete results from its Phase 1 clinical trial of losmapimod, which is being developed for the treatment of facioscapulohumeral muscular dystrophy (FSHD).

African swine fever, a lethal viral disease affecting pigs, is responsible for serious production and economic losses and is a global threat to food security

OmniPathology today announced the launch of its COVID-19 Lab Developed Test LDT. In response to the US Food and Drug Administration (FDA) policy announcement on February 29, 2020, seeking high complexity laboratories to start developing diagnostic tests for Coronavirus to address the COVID-19 outbreak.